PlainRecalls
FDA Drug Moderate Class II Terminated

Absorica (isotretinoin) Capsules, 25 mg, Packaged in 3 x 10 Count Blister Cards/Box, Rx Only. Manufactured for: RANBAXY LABORATORIES, INC Jacksonville, FL 32257 USA. NDC: 10631-133-31.

Reported: August 12, 2015 Initiated: June 26, 2015 #D-1288-2015

Product Description

Absorica (isotretinoin) Capsules, 25 mg, Packaged in 3 x 10 Count Blister Cards/Box, Rx Only. Manufactured for: RANBAXY LABORATORIES, INC Jacksonville, FL 32257 USA. NDC: 10631-133-31.

Reason for Recall

Incorrect/Undeclared Excipients: Product contains undeclared FD&C Yellow No. 5 in the capsule shell.

Details

Recalling Firm
Ranbaxy Inc.
Units Affected
9,229 Boxes
Distribution
Nationwide
Location
Princeton, NJ

Frequently Asked Questions

What product was recalled?
Absorica (isotretinoin) Capsules, 25 mg, Packaged in 3 x 10 Count Blister Cards/Box, Rx Only. Manufactured for: RANBAXY LABORATORIES, INC Jacksonville, FL 32257 USA. NDC: 10631-133-31.. Recalled by Ranbaxy Inc.. Units affected: 9,229 Boxes.
Why was this product recalled?
Incorrect/Undeclared Excipients: Product contains undeclared FD&C Yellow No. 5 in the capsule shell.
Which agency issued this recall?
This recall was issued by the FDA Drug on August 12, 2015. Severity: Moderate. Recall number: D-1288-2015.